Search

Your search keyword '"Shah, Svati H."' showing total 1,111 results
Start Over Author "Shah, Svati H."
1,111 results on '"Shah, Svati H."'

1. Genome-wide meta-analyses of restless legs syndrome yield insights into genetic architecture, disease biology and risk prediction

Author

Schormair, Barbara, Zhao, Chen, Bell, Steven, Didriksen, Maria, Nawaz, Muhammad S., Schandra, Nathalie, Stefani, Ambra, Högl, Birgit, Dauvilliers, Yves, Bachmann, Cornelius G., Kemlink, David, Sonka, Karel, Paulus, Walter, Trenkwalder, Claudia, Oertel, Wolfgang H., Hornyak, Magdolna, Teder-Laving, Maris, Metspalu, Andres, Hadjigeorgiou, Georgios M., Polo, Olli, Fietze, Ingo, Ross, Owen A., Wszolek, Zbigniew K., Ibrahim, Abubaker, Bergmann, Melanie, Kittke, Volker, Harrer, Philip, Dowsett, Joseph, Chenini, Sofiene, Ostrowski, Sisse Rye, Sørensen, Erik, Erikstrup, Christian, Pedersen, Ole B., Topholm Bruun, Mie, Nielsen, Kaspar R., Butterworth, Adam S., Soranzo, Nicole, Ouwehand, Willem H., Roberts, David J., Danesh, John, Burchell, Brendan, Furlotte, Nicholas A., Nandakumar, Priyanka, Earley, Christopher J., Ondo, William G., Xiong, Lan, Desautels, Alex, Perola, Markus, Vodicka, Pavel, Dina, Christian, Stoll, Monika, Franke, Andre, Lieb, Wolfgang, Stewart, Alexandre F. R., Shah, Svati H., Gieger, Christian, Peters, Annette, Rye, David B., Rouleau, Guy A., Berger, Klaus, Stefansson, Hreinn, Ullum, Henrik, Stefansson, Kari, Hinds, David A., Di Angelantonio, Emanuele, Oexle, Konrad, and Winkelmann, Juliane

Published
2024
Full Text
View/download PDF

9. Lipoprotein subclasses are associated with Hepatic steatosis: insights from the prospective multicenter imaging study for the evaluation of chest pain (PROMISE) clinical trial

Author

Karady, Julia, McGarrah, Robert W, Nguyen, Maggie, Giamberardino, Stephanie N, Meyersohn, Nandini, Lu, Michael T, Staziaki, Pedro V, Puchner, Stefan B, Bittner, Daniel O, Foldyna, Borek, Mayrhofer, Thomas, Connelly, Margery A, Tchernof, Andre, White, Phillip J, Nasir, Khurram, Corey, Kathleen, Voora, Deepak, Pagidipati, Neha, Ginsburg, Geoffrey S, Kraus, William E, Hoffmann, Udo, Douglas, Pamela S, Shah, Svati H, and Ferencik, Maros

Published
2024
Full Text
View/download PDF

11. Metabolomic profiling during ex situ normothermic perfusion before heart transplantation defines patterns of substrate utilization and correlates with markers of allograft injury

Author

Truby, Lauren K., Kwee, Lydia Coulter, Bowles, Dawn E., Casalinova, Sarah, Ilkayeva, Olga, Muehlbauer, Michael J., Huebner, Janet L., Holley, Christopher L., DeVore, Adam D., Patel, Chetan B., Kang, Lillian, Pla, Michelle Mendiola, Gross, Ryan, McGarrah, Robert W., Schroder, Jacob N., Milano, Carmelo A., and Shah, Svati H.

Published
2024
Full Text
View/download PDF

14. Transmethylamine‐N‐Oxide Is Associated With Diffuse Cardiac Fibrosis in People Living With HIV

Author

Colaco, Nalini A, Wang, Teresa S, Ma, Yifei, Scherzer, Rebecca, Ilkayeva, Olga R, Desvigne‐Nickens, Patrice, Braunwald, Eugene, Hernandez, Adrian F, Butler, Javed, Shah, Svati H, Shah, Sanjiv J, and Hsue, Priscilla Y

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Clinical Research, HIV/AIDS, Biomedical Imaging, Heart Disease, Heart Disease - Coronary Heart Disease, Nutrition, Cardiovascular, Prevention, 2.1 Biological and endogenous factors, Aetiology, Good Health and Well Being, Aged, Anti-HIV Agents, Bacteria, Biomarkers, Cardiomyopathies, Cross-Sectional Studies, Female, Fibrosis, Gastrointestinal Microbiome, HIV Infections, HIV Long-Term Survivors, Humans, Male, Methylamines, Middle Aged, Myocardium, Predictive Value of Tests, Risk Assessment, Risk Factors, United States, diastolic dysfunction, HIV, myocardial fibrosis, transmethylamine-N-oxide, transmethylamine‐N‐oxide, Cardiorespiratory Medicine and Haematology, Cardiovascular medicine and haematology
Abstract

Background People living with HIV are at increased risk of developing diastolic dysfunction, heart failure, and sudden cardiac death, all of which have been characterized by higher levels of myocardial fibrosis. Transmethylamine-N-oxide (TMAO), a dietary gut metabolite, is linked to the development of myocardial fibrosis in animal models. However, it is unclear whether TMAO plays a role in the development of myocardial fibrosis in people living with HIV. Methods and Results The study population consisted of participants enrolled in the multisite cross-sectional study called CHART-HIV (Characterizing Heart Function on Anti-Retroviral Therapy). Participants underwent echocardiography, cardiac magnetic resonance imaging, biomarker analysis, and targeted assessment of gut-related circulating metabolites; diastolic dysfunction was determined by study-specific criteria. Multivariable linear regression models were performed to examine the relationship of gut-related metabolites with serum and imaging measures of myocardial fibrosis. Models were adjusted for traditional cardiovascular, inflammatory, and HIV-related risk factors. Diastolic dysfunction was present in 94 of 195 individuals (48%) in CHART-HIV; this cohort demonstrated higher prevalence of hypertension, hyperlipidemia, and chronic kidney disease as well as higher plasma levels of both TMAO and choline. TMAO levels were associated with parameters reflecting increased left ventricular filling pressures and with a marker of the innate immune system. TMAO levels correlated with diffuse myocardial fibrosis (R=0.35; P

Published
2021

15. Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity

Author

Akbari, Parsa, Gilani, Ankit, Sosina, Olukayode, Kosmicki, Jack A, Khrimian, Lori, Fang, Yi-Ya, Persaud, Trikaldarshi, Garcia, Victor, Sun, Dylan, Li, Alexander, Mbatchou, Joelle, Locke, Adam E, Benner, Christian, Verweij, Niek, Lin, Nan, Hossain, Sakib, Agostinucci, Kevin, Pascale, Jonathan V, Dirice, Ercument, Dunn, Michael, Center‡, Regeneron Genetics, Collaboration‡, DiscovEHR, Kraus, William E, Shah, Svati H, Chen, Yii-Der I, Rotter, Jerome I, Rader, Daniel J, Melander, Olle, Still, Christopher D, Mirshahi, Tooraj, Carey, David J, Berumen-Campos, Jaime, Kuri-Morales, Pablo, Alegre-Díaz, Jesus, Torres, Jason M, Emberson, Jonathan R, Collins, Rory, Balasubramanian, Suganthi, Hawes, Alicia, Jones, Marcus, Zambrowicz, Brian, Murphy, Andrew J, Paulding, Charles, Coppola, Giovanni, Overton, John D, Reid, Jeffrey G, Shuldiner, Alan R, Cantor, Michael, Kang, Hyun M, Abecasis, Goncalo R, Karalis, Katia, Economides, Aris N, Marchini, Jonathan, Yancopoulos, George D, Sleeman, Mark W, Altarejos, Judith, Della Gatta, Giusy, Tapia-Conyer, Roberto, Schwartzman, Michal L, Baras, Aris, Ferreira, Manuel AR, and Lotta, Luca A

Subjects
Prevention, Human Genome, Nutrition, Genetics, Obesity, Aetiology, 2.1 Biological and endogenous factors, Metabolic and endocrine, Stroke, Oral and gastrointestinal, Cardiovascular, Animals, Body Mass Index, Exome, Genetic Variation, Humans, Mice, Mice, Knockout, Receptors, G-Protein-Coupled, Sequence Analysis, DNA, Weight Gain, Regeneron Genetics Center, DiscovEHR Collaboration, General Science & Technology
Abstract

Large-scale human exome sequencing can identify rare protein-coding variants with a large impact on complex traits such as body adiposity. We sequenced the exomes of 645,626 individuals from the United Kingdom, the United States, and Mexico and estimated associations of rare coding variants with body mass index (BMI). We identified 16 genes with an exome-wide significant association with BMI, including those encoding five brain-expressed G protein-coupled receptors (CALCR, MC4R, GIPR, GPR151, and GPR75). Protein-truncating variants in GPR75 were observed in ~4/10,000 sequenced individuals and were associated with 1.8 kilograms per square meter lower BMI and 54% lower odds of obesity in the heterozygous state. Knock out of Gpr75 in mice resulted in resistance to weight gain and improved glycemic control in a high-fat diet model. Inhibition of GPR75 may provide a therapeutic strategy for obesity.

Published
2021

17. Clinical and Echocardiographic Diversity Associated With Physical Fitness in the Project Baseline Health Study: Implications for Heart Failure Staging

Author

CAUWENBERGHS, NICHOLAS, HADDAD, FRANCOIS, DAUBERT, MELISSA A., CHATTERJEE, RANEE, SALERNO, MICHAEL, MEGA, JESSICA L., HEIDENREICH, PAUL, HERNANDEZ, ADRIAN, AMSALLEM, MYRIAM, KOBAYASHI, YUKARI, MAHAFFEY, KENNETH W., SHAH, SVATI H., BLOOMFIELD, GERALD S., KUZNETSOVA, TATIANA, and DOUGLAS, PAMELA S.

Published
2023
Full Text
View/download PDF

19. Creatine and creatinine quantified using nuclear magnetic resonance: A method validation study and clinical associations between circulating creatine and fatigue in kidney transplant recipients

Author

Post, Adrian, Garcia, Erwin, Shalaurova, Irina, Matyus, Steven P., González-Delgado, Jessica M., Doorenbos, Caecilia S.E., van der Veen, Yvonne, Shah, Svati H., Kraus, William E., Kremer, Daan, Knobbe, Tim J., Bakker, Stephan J.L., Dullaart, Robin P.F., and Connelly, Margery A.

Published
2023
Full Text
View/download PDF

27. Coronary Atherosclerosis Across the Glycemic Spectrum Among Asymptomatic Adults: The Miami Heart Study at Baptist Health South Florida

Author

Patel, Kershaw V., Budoff, Matthew J., Valero-Elizondo, Javier, Lahan, Shubham, Ali, Shozab S., Taha, Mohamad B., Blaha, Michael J., Blankstein, Ron, Shapiro, Michael D., Pandey, Ambarish, Arias, Lara, Feldman, Theodore, Cury, Ricardo C., Cainzos-Achirica, Miguel, Shah, Svati H., Ziffer, Jack A., Fialkow, Jonathan, and Nasir, Khurram

Published
2023
Full Text
View/download PDF

28. Diastolic Dysfunction in Patients With Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results From the CHART Study

Author

Butler, Javed, Greene, Stephen J, Shah, Svati H, Shah, Sanjiv J, Anstrom, Kevin J, Kim, Raymond J, Kalogeropoulos, Andreas P, Velazquez, Eric J, Hernandez, Adrian F, Desvigne-Nickens, Patrice, Scherzer, Rebecca, Hsue, Priscilla Y, and Braunwald, Eugene

Subjects
Medical Microbiology, Biomedical and Clinical Sciences, Clinical Sciences, HIV/AIDS, Cardiovascular, Infectious Diseases, Clinical Research, Heart Disease, Aetiology, 2.1 Biological and endogenous factors, Cardiomyopathies, Case-Control Studies, Cross-Sectional Studies, HIV, HIV Infections, Heart Atria, Heart Failure, Humans, Quality of Life, Ventricular Dysfunction, Left, Antiretroviral therapy, diastolic dysfunction, human immunodeficiency virus, myocardial fibrosis, Cardiorespiratory Medicine and Haematology, Nursing, Cardiovascular System & Hematology, Cardiovascular medicine and haematology, Clinical sciences
Abstract

BackgroundDiastolic dysfunction (DD) is common and occurs at an earlier age among human immunodeficiency virus-infected (HIV+) individuals, but the mechanisms and consequences of DD among HIV+ individuals are unclear.Methods and resultsThe Characterization of Heart Function on Antiretroviral Therapy (CHART) study was a multicenter cross-sectional case-control study of treated and virally suppressed HIV+ individuals with (DD+) and without DD (DD-). All patients had normal ejection fraction (>50%), no significant valvular disease, and no history of coronary revascularization or persistent atrial fibrillation. Overall, 94 DD+ and 101 DD- patients were included. DD+ patients were older with higher body mass index (BMI) and more likely to have hypertension, renal dysfunction, and dyslipidemia. Groups were similar with respect to sex, race, CD4 count, and HIV RNA copies. N-terminal pro-B-type natriuretic peptide levels (median 36 [23, 85] vs 26 [12, 49] pg/mL, P < .01) and high-sensitivity troponin I (3.6 [2.6, 5.1] vs 2.5 [1.8, 3.5] pg/mL, P < .01) were higher among DD+ patients. The latter had similar left atrial size, but increased stiffness (conduit strain: 23.5 [17.5, 36.9] vs 30.0 [22.9, 37.0], P < .01) and impaired relaxation (reservoir strain: 39.7 [32.0, 58.0] vs 45.9 [37.0, 60.6], P = .04). On cardiac magnetic resonance, the prevalence of focal fibrosis was higher among DD+ patients (19.0% vs 5.3%, P < .01). DD+ patients demonstrated higher levels of carboxyl-terminal telopeptide of collagen type I (P = .04), and trends toward higher interleukin-6 and oxidized low-density lipoprotein levels (P ≤ .08). Kansas City Cardiomyopathy Questionnaire physical limitation (87.1±21.4 vs 93.1±18.1, P = .01) and symptom frequency scores were lower among DD+ patients (86.0±21.5 vs 92.5±16.8, P = .01).ConclusionsIn this contemporary HIV+ population receiving antiretroviral therapy, DD was associated with multiple alterations in cardiac structure and function, including myocardial fibrosis and left atrial abnormalities, and worse quality of life. Further studies are needed to assess longitudinal changes in these parameters and their potential as therapeutic targets to prevent progressive cardiac remodeling and dysfunction in HIV.

Published
2020

32. Association of left ventricular diastolic function with coronary artery calcium score: A Project Baseline Health Study

Author

Haddad, Francois, Cauwenberghs, Nicholas, Daubert, Melissa A., Kobayashi, Yukari, Bloomfield, Gerald S., Fleischman, Dominik, Koweek, Lynne, Maron, David J., Rodriguez, Fatima, Liao, Yaping Joyce, Moneghetti, Kegan, Amsallem, Myriam, Mega, Jessica, Hernandez, Adrian, Califf, Robert, Mahaffey, Kenneth W., Shah, Svati H., Kuznetsova, Tatiana, and Douglas, Pamela S.

Published
2022
Full Text
View/download PDF

40. Lipoprotein(a) and Coronary Plaque in Asymptomatic Individuals: The Miami Heart Study at Baptist Health South Florida.

Author

Mszar, Reed, Cainzos-Achirica, Miguel, Valero-Elizondo, Javier, Lahan, Shubham, Al-Kindi, Sadeer G., Quispe, Renato, Ali, Shozab S., Arias, Lara, Saxena, Anshul, Shah, Svati H., Cury, Ricardo C., Budoff, Matthew J., Blaha, Michael J., Shapiro, Michael D., Sharma, Garima, Santos, Raul D., Blankstein, Ron, Feldman, Theodore, Fialkow, Jonathan, and Nasir, Khurram

Abstract

BACKGROUND: Elevated levels of lipoprotein(a) (Lp(a)) are independently associated with an increased risk of atherosclerotic cardiovascular disease events. However, the mechanisms driving this association are poorly understood. We aimed to evaluate the association between Lp(a) and coronary plaque characteristics in a contemporary US cohort without clinical atherosclerotic cardiovascular disease, undergoing coronary computed tomography angiography, the noninvasive gold standard for the assessment of coronary atherosclerosis. We used baseline data from the Miami Heart Study--a community-based, prospective cohort study--which included asymptomatic adults aged 40 to 65 years evaluated using coronary computed tomography angiography. Those taking any lipid-lowering therapies were excluded. Elevated Lp(a) was defined as =125 nmol/L. Outcomes included any plaque, coronary artery calcium score >0, maximal stenosis =50%, presence of any high-risk plaque feature (positive remodeling, spotty calcification, low-attenuation plaque, napkin ring), and the presence of =2 high-risk plaque features. RESULTS: Among 1795 participants (median age, 52 years; 54.3% women; 49.6% Hispanic), 291 (16.2%) had Lp(a) =125 nmol/L. In unadjusted analyses, individuals with Lp(a) =125 nmol/L had a higher prevalence of all outcomes compared with Lp(a) <125 nmol/L, although differences were only statistically significant for the presence of any coronary plaque and =2 high-risk features. In multivariable models, elevated Lp(a) was independently associated with the presence of any coronary plaque (odds ratio, 1.40, [95% CI, 1.05-1.86]) and with =2 high-risk features (odds ratio, 3.94, [95% CI, 1.82-8.52]), although only 35 participants had this finding. Among participants with a coronary artery calcium score of 0 (n=1200), those with Lp(a) =125 nmol/L had a significantly higher percentage of any plaque compared with those with Lp(a) <125 nmol/L (24.2% versus 14.2%; P<0.001). CONCLUSIONS:' In this contemporary analysis, elevated Lp(a) was independently associated with the presence of coronary plaque. Larger studies are needed to confirm the strong association observed with the presence of multiple high-risk coronary plaque features. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

41. Diastolic Dysfunction in Individuals With Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Antiretroviral Therapy (CHART) Study

Author

Butler, Javed, Kalogeropoulos, Andreas P, Anstrom, Kevin J, Hsue, Priscilla Y, Kim, Raymond J, Scherzer, Rebecca, Shah, Sanjiv J, Shah, Svati H, Velazquez, Eric J, Hernandez, Adrian F, Desvigne-Nickens, Patrice, and Braunwald, Eugene

Subjects
Medical Microbiology, Biomedical and Clinical Sciences, Immunology, Infectious Diseases, Cardiovascular, HIV/AIDS, Clinical Research, Heart Disease, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, 2.1 Biological and endogenous factors, Aetiology, Infection, Good Health and Well Being, Anti-Retroviral Agents, Global Health, HIV, HIV Infections, Heart Failure, Diastolic, Humans, Incidence, Prognosis, Stroke Volume, Ventricular Function, Left, Human immunodeficiency virus, diastolic dysfunction, heart failure, pathophysiology, Cardiorespiratory Medicine and Haematology, Clinical Sciences, Nursing, Cardiovascular System & Hematology, Cardiovascular medicine and haematology, Clinical sciences
Abstract

Antiretroviral therapy (ART) has been associated with a shift in the epidemiology of human immunodeficiency virus (HIV)-associated cardiomyopathy from a phenotype of primarily left ventricular (LV) systolic dysfunction to LV diastolic dysfunction (DD). Patients with HIV receiving ART have higher rates of DD compared with age-matched control subjects and develop DD at a younger age. However, little is known about the natural history and pathogenesis of DD in virally suppressed HIV-infected patients. Current evidence suggests that immune processes modulate the risk for cardiac involvement in HIV-infected persons. Ongoing inflammation appears to have myocardial effects, and accelerated myocardial fibrosis appears to be a key mediator of HIV-induced DD. The Characterizing Heart Function on Antiretroviral Therapy (CHART) study aims to systematically investigate determinants, mechanisms, and consequences of DD in HIV-infected patients. We will compare ART-treated virally suppressed HIV-infected individuals with and without DD and HIV- individuals with DD regarding (1) systemic inflammation, myocardial stress, and subclinical myocardial necrosis as indicated by circulating biomarkers; (2) immune system activation as indicated by cell surface receptors; (3) myocardial fibrosis according to cardiac magnetic resonance examination; (4) markers of fibrosis and remodeling, oxidative stress, and hypercoagulability; (5) left atrial function according to echocardiographic examination; (6) myocardial stress and subclinical necrosis as indicated by circulating biomarkers; (7) proteomic and metabolic profiles; and (8) phenotype signatures derived from clinical, biomarker, and imaging data.

Published
2018

42. Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes

Author

Gusarova, Viktoria, O’Dushlaine, Colm, Teslovich, Tanya M, Benotti, Peter N, Mirshahi, Tooraj, Gottesman, Omri, Van Hout, Cristopher V, Murray, Michael F, Mahajan, Anubha, Nielsen, Jonas B, Fritsche, Lars, Wulff, Anders Berg, Gudbjartsson, Daniel F, Sjögren, Marketa, Emdin, Connor A, Scott, Robert A, Lee, Wen-Jane, Small, Aeron, Kwee, Lydia C, Dwivedi, Om Prakash, Prasad, Rashmi B, Bruse, Shannon, Lopez, Alexander E, Penn, John, Marcketta, Anthony, Leader, Joseph B, Still, Christopher D, Kirchner, H Lester, Mirshahi, Uyenlinh L, Wardeh, Amr H, Hartle, Cassandra M, Habegger, Lukas, Fetterolf, Samantha N, Tusie-Luna, Teresa, Morris, Andrew P, Holm, Hilma, Steinthorsdottir, Valgerdur, Sulem, Patrick, Thorsteinsdottir, Unnur, Rotter, Jerome I, Chuang, Lee-Ming, Damrauer, Scott, Birtwell, David, Brummett, Chad M, Khera, Amit V, Natarajan, Pradeep, Orho-Melander, Marju, Flannick, Jason, Lotta, Luca A, Willer, Cristen J, Holmen, Oddgeir L, Ritchie, Marylyn D, Ledbetter, David H, Murphy, Andrew J, Borecki, Ingrid B, Reid, Jeffrey G, Overton, John D, Hansson, Ola, Groop, Leif, Shah, Svati H, Kraus, William E, Rader, Daniel J, Chen, Yii-Der I, Hveem, Kristian, Wareham, Nicholas J, Kathiresan, Sekar, Melander, Olle, Stefansson, Kari, Nordestgaard, Børge G, Tybjærg-Hansen, Anne, Abecasis, Goncalo R, Altshuler, David, Florez, Jose C, Boehnke, Michael, McCarthy, Mark I, Yancopoulos, George D, Carey, David J, Shuldiner, Alan R, Baras, Aris, Dewey, Frederick E, and Gromada, Jesper

Subjects
Biological Sciences, Biomedical and Clinical Sciences, Genetics, Diabetes, Atherosclerosis, Cardiovascular, Metabolic and endocrine, Amino Acid Substitution, Angiopoietin-Like Protein 4, Animals, Blood Glucose, Case-Control Studies, Diabetes Mellitus, Type 2, Female, Gene Silencing, Genetic Association Studies, Genetic Variation, Heterozygote, Homeostasis, Humans, Insulin Resistance, Lipoprotein Lipase, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Risk Factors, Exome Sequencing
Abstract

Angiopoietin-like 4 (ANGPTL4) is an endogenous inhibitor of lipoprotein lipase that modulates lipid levels, coronary atherosclerosis risk, and nutrient partitioning. We hypothesize that loss of ANGPTL4 function might improve glucose homeostasis and decrease risk of type 2 diabetes (T2D). We investigate protein-altering variants in ANGPTL4 among 58,124 participants in the DiscovEHR human genetics study, with follow-up studies in 82,766 T2D cases and 498,761 controls. Carriers of p.E40K, a variant that abolishes ANGPTL4 ability to inhibit lipoprotein lipase, have lower odds of T2D (odds ratio 0.89, 95% confidence interval 0.85-0.92, p = 6.3 × 10-10), lower fasting glucose, and greater insulin sensitivity. Predicted loss-of-function variants are associated with lower odds of T2D among 32,015 cases and 84,006 controls (odds ratio 0.71, 95% confidence interval 0.49-0.99, p = 0.041). Functional studies in Angptl4-deficient mice confirm improved insulin sensitivity and glucose homeostasis. In conclusion, genetic inactivation of ANGPTL4 is associated with improved glucose homeostasis and reduced risk of T2D.

Published
2018

47. Abstract 14174: Abnormal Exercise Electrocardiography With Normal Stress Echocardiography is Associated With Increased Subclinical Coronary Atherosclerosis: Insights From the Project Baseline Health Study

Author

Duran, Jessica M, Nguyen, Maggie, Haddad, Francois, Cauwenberghs, Nicholas, Kuznetsova, Tatiana, Bloomfield, Gerald S, Mahaffey, Kenneth, Hernandez, Adrian F, Mega, Jessica L, Short, Sarah, Douglas, Pamela S, Shah, Svati H, and Daubert, Melissa A

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results